Standalone figures · ₹ crore
| ₹ Cr | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1,871 | 2,119 | 2,037 | 2,282 | 2,144 | 2,424 | 2,188 | 2,503 | 2,411 | 2,551 | 2,361 | 2,987 | |
| COGS | 499 | 618 | 633 | 627 | 625 | 622 | 533 | 677 | 684 | 692 | 608 | 696 |
| Gross profit | 1,372 | 1,502 | 1,403 | 1,655 | 1,519 | 1,802 | 1,655 | 1,826 | 1,726 | 1,859 | 1,753 | 2,291 |
| 1,278 | 1,399 | 1,298 | 1,533 | 1,403 | 1,678 | 1,511 | 1,678 | 1,568 | 1,683 | 1,589 | 2,121 | |
| 94 | 103 | 105 | 123 | 116 | 124 | 144 | 148 | 158 | 176 | 164 | 170 | |
| OPM % | 5% | 4.9% | 5.2% | 5.4% | 5.4% | 5.1% | 6.6% | 5.9% | 6.6% | 6.9% | 7% | 5.7% |
| Depreciation | 28 | 26 | 26 | 28 | 28 | 27 | 33 | 34 | 38 | 41 | 41 | 42 |
| Interest | 29 | 31 | 33 | 36 | 40 | 44 | 45 | 45 | 49 | 47 | 26 | 25 |
| 11 | 5 | 5 | 3 | 4 | 6 | 2 | 1 | 2 | -0 | 39 | 0 | |
| Profit before tax | 48 | 50 | 51 | 62 | 53 | 58 | 68 | 70 | 72 | 88 | 136 | 103 |
| Tax | 12 | 12 | 13 | 15 | 14 | 15 | 18 | 17 | 19 | 23 | 26 | 26 |
| Tax % | 25.3% | 24.5% | 26.2% | 24.6% | 25.9% | 25% | 26.1% | 24.6% | 25.6% | 26.1% | 18.8% | 25.4% |
| 36 | 38 | 38 | 47 | 39 | 44 | 50 | 53 | 54 | 65 | 110 | 77 | |
| PAT margin % | 1.9% | 1.8% | 1.9% | 2.1% | 1.8% | 1.8% | 2.3% | 2.1% | 2.2% | 2.6% | 4.7% | 2.6% |
| EPS (₹) | 11.5 | 12.2 | 12.2 | 15.1 | 12.7 | 14.2 | 16.3 | 17.1 | 8.7 | 10.4 | 17.3 | 11.4 |
| Results filing | — | — | — | — | — | — | — | Results filing for Jun 2025 | Results filing for Sep 2025 | Results filing for Dec 2025 | Results filing for Mar 2026 | — |
| vs same quarter last year | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % | +14.5% | +39% | +26.1% | +20.6% | +14.6% | +14.4% | +7.4% | +9.7% |
As reported in NSE results XBRL. Segment result is before tax and finance costs.
Latest reported period · 30 Jun 2026 · ₹ crore
| Segment | Revenue | Result | Assets | Liabilities | Capital employed |
|---|---|---|---|---|---|
| Potable Spirits | 2,218.67 | 75.03 | 632.16 | 385.41 | 246.75 |
| Bio-based Specialities and Performance Chemicals | 361.73 | 31.75 | 3,514.26 | 577.54 | 2,936.72 |
| +12.5% |
| +5.3% |
| +7.9% |
| +19.3% |
| PAT YoY % | +58.7% | +183.1% | -5.9% | +15.3% | +10.6% | +16% | +33.4% | +13.1% | +36.7% | +48.9% | +119% | +44.9% |
| Bio-Fuel | 323.22 | 27.03 | 1,538.06 | 100.2 | 1,437.86 |
| Ennature Biopharma | 83.3 | 7.25 | 417.28 | 107.57 | 309.71 |
₹ crore by quarter